Cargando…

The Effect of CytoSorb on Inflammatory Markers in Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials*

OBJECTIVES: The effectiveness of CytoSorb at removing inflammatory mediators in critically ill patients is controversial. DATA SOURCES: Electronic databases were searched from inception to May 2023. STUDY SELECTION: Randomized controlled trials reporting the effects of CytoSorb therapy on inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heymann, Marc, Schorer, Raoul, Putzu, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645103/ https://www.ncbi.nlm.nih.gov/pubmed/37607074 http://dx.doi.org/10.1097/CCM.0000000000006007

Ejemplares similares

Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta‐analysis of randomized controlled trials
por: Heymann, Marc, et al.
Publicado: (2022)

Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement
por: Putzu, Alessandro, et al.
Publicado: (2021)

CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015)

Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)

Pancreatitis cytosorbents (CytoSorb) inflammatory cytokine removal: A Prospective Study (PACIFIC)
por: Huber, Wolfgang, et al.
Publicado: (2019)

Efficacy of CytoSorb®: a systematic review and meta-analysis
por: Becker, Sören, et al.
Publicado: (2023)

Impact of CytoSorb® on interleukin-6 in cardiac surgery
por: Geisler, Daniela, et al.
Publicado: (2023)

Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial
por: Papazisi, Olga, et al.
Publicado: (2022)

Hemoadsorption by CytoSorb in septic patients: a case series
por: Kogelmann, Klaus, et al.
Publicado: (2017)

CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
por: Honore, Patrick M., et al.
Publicado: (2020)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
por: Schneider, Antoine G., et al.
Publicado: (2021)

Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case
por: Cirstoveanu, Catalin Gabriel, et al.
Publicado: (2017)

Use of CytoSorb in Traumatic Amputation of the Forearm and Severe Septic Shock
por: Steltzer, Heinz, et al.
Publicado: (2017)

Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
por: Mehta, Yatin, et al.
Publicado: (2021)

No clinically relevant removal of meropenem by cytokine adsorber CytoSorb(®) in critically ill patients with sepsis or septic shock
por: Liebchen, Uwe, et al.
Publicado: (2021)

The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2021)

Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study
por: Bottari, Gabriella, et al.
Publicado: (2023)

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis
por: Saldaña-Gastulo, Jiovany Jhan Carlos, et al.
Publicado: (2023)

CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis
por: Wei, Shilin, et al.
Publicado: (2023)

Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
por: Poli, Elettra C, et al.
Publicado: (2019)

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori, et al.
Publicado: (2023)

Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?
por: Ceruti, Samuele, et al.
Publicado: (2021)

Hemoadsorption with CytoSorb(®) and the early course of linezolid plasma concentration during septic shock
por: Köhler, Thomas, et al.
Publicado: (2021)

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy
por: Scheier, Joerg, et al.
Publicado: (2022)

Cytokine hemoadsorption with CytoSorb(®) in post-cardiac arrest syndrome, a pilot randomized controlled trial
por: Monard, Céline, et al.
Publicado: (2023)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
por: Köhler, Thomas, et al.
Publicado: (2021)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial
por: Stockmann, Helena, et al.
Publicado: (2020)

CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
por: Acevedo, Alice-Christin, et al.
Publicado: (2021)

Hemoadsorption in ‘Liver Indication’—Analysis of 109 Patients’ Data from the CytoSorb International Registry
por: Ocskay, Klementina, et al.
Publicado: (2021)

Sublingual Microcirculatory Evaluation of Extracorporeal Hemoadsorption with CytoSorb® in Abdominal Sepsis: A Case Report
por: Duran, Servet, et al.
Publicado: (2022)

Does the cytokine adsorber CytoSorb(®) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
por: Scharf, Christina, et al.
Publicado: (2022)

Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
por: Lang, Corinna N., et al.
Publicado: (2020)

Hemoadsorption of cytokines by CytoSorb filter: a simulation study without human factor—pilot is the difference
por: Nadeem, Rashid, et al.
Publicado: (2020)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response
por: Supady, Alexander, et al.
Publicado: (2021)

Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb(®)—Basics, Indications and Perspectives—A Scoping Review
por: Köhler, Thomas, et al.
Publicado: (2021)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
por: Alarie, Marianne, et al.
Publicado: (2022)

Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis
por: Popescu, Mihai, et al.
Publicado: (2023)

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
por: Jansen, Aron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c8rtfp7995l92grjm5k490nqjc